Lindhorst · Cell death & disease 2021 · preclinical animal and in vivo imaging study · n=?

Adipocyte death triggers a pro-inflammatory response and induces metabolic activation of resident macrophages.

Cited 140 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Preclinical animal model and live-tissue imaging study without human clinical data

PubMed 34091595 · doi:10.1038/s41419-021-03872-9 · record verified 2026-08-28

What was done

Established a laser injury model to ablate individual adipocytes in living adipose tissue from double reporter mice (GFP-labeled adipose tissue macrophages [ATMs] and tdTomato-labeled adipocytes) to track ATM-adipocyte interactions and the timeline of crown-like structure (CLS) formation via live imaging. Evaluated ATM metabolic activation, the role of adipocyte size in efferocytosis, and the requirement for monocyte recruitment using parabiotic mouse models.

What was found

The abstract reports no numerical values or statistical effect sizes. Qualitatively, adipocyte death triggered CLS formation, increased lipid metabolism, and induced a localized pro-inflammatory, metabolically activated phenotype in resident ATMs even in lean animals under homeostatic conditions. The authors identified adipocyte cell size as exceeding the threshold for normal anti-inflammatory efferocytosis. Parabiotic mouse experiments indicated that this response was mediated by resident ATMs without significant recruitment of circulating blood monocytes.

Why it matters

Demonstrates that individual adipocyte death is sufficient to trigger local macrophage activation and inflammation driven by physical cell size constraints, offering a mechanistic model for how adipose tissue inflammation can arise independently of systemic obesity.

Limits

Study was conducted exclusively in mice using an artificial laser injury model rather than spontaneous physiological adipocyte death. No numerical data, sample sizes, or variance measures are reported in the abstract. Applicability to chronic human obesity and metabolic disease remains unverified.

Cited by